NCI (NCIT) ALERT: J&W Investigates Proposed Sale of NCI, Inc.; Is $20 a Fair Price?

SAN DIEGO, July 3, 2017

On July 3, 2017, NCI announced it had signed a definitive merger agreement with H.I.G. Under the terms of the agreement, H.I.G. will acquire all outstanding shares of NCI's Class A and Class B common stock for $20.00 per share in cash.

The investigation concerns whether the NCI board failed to satisfy its duties to the Company shareholders, including whether the board had adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for NCI shares of common stock. Nationally recognized Johnson & Weaver is investigating whether the proposed deal price represents adequate consideration, especially given one Wall Street analyst has a $26.00 price target on the stock. 

If you are a shareholder of NCI and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonandweaver.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson & Weaver, LLP:
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
jimb@johnsonandweaver.com